Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Vail

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Guiding the optimal translation of new cancer treatments from canine to human cancer patientsChand Khanna, Cheryl London, David Vail, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|July 27, 2020
Definitive-intent intensity modulated radiotherapy for modified-Adams' stage 4 canine sinonasal cancer: A retrospective study of 29 cases (2011-2017)Audrey Stevens, Michelle Turek, David Vail, et al.
Journal of the American Animal Hospital Association|May 3, 2008
Four-fraction radiation therapy for macroscopic soft tissue sarcomas in 16 dogsJessica Lawrence, Lisa Forrest, William Adams, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|October 6, 2023
Intensity-modulated radiotherapy and chemotherapy for canine right atrial tumors: A retrospective study of seven dogsSteven Moirano, Michelle Turek, Diana Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphomaAnthony Rusk, Elizabeth Cozzi, Marty Stebbins, et al.
Viruses|March 28, 2024
The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary CancerDiana Sánchez, Gabriela Cesarman-Maus, Laura Romero, et al.
Veterinary and Comparative Oncology|April 30, 2020
Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trialsCorey F Saba, Craig Clifford, Kristine Burgess, et al.
Plos One|June 20, 2015
Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant MelanomaMelissa Paoloni, Christina Mazcko, Kimberly Selting, et al.
Plos One|March 31, 2009
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculatureMelissa C Paoloni, Anita Tandle, Christina Mazcko, et al.
Plos One|March 19, 2014
Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trialsMelissa Paoloni, Craig Webb, Christina Mazcko, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2009
Guiding the optimal translation of new cancer treatments from canine to human cancer patientsChand Khanna, Cheryl London, David Vail, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|July 27, 2020
Definitive-intent intensity modulated radiotherapy for modified-Adams' stage 4 canine sinonasal cancer: A retrospective study of 29 cases (2011-2017)Audrey Stevens, Michelle Turek, David Vail, et al.
Journal of the American Animal Hospital Association|May 3, 2008
Four-fraction radiation therapy for macroscopic soft tissue sarcomas in 16 dogsJessica Lawrence, Lisa Forrest, William Adams, et al.
Veterinary Radiology & Ultrasound : the Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association|October 6, 2023
Intensity-modulated radiotherapy and chemotherapy for canine right atrial tumors: A retrospective study of seven dogsSteven Moirano, Michelle Turek, Diana Sanchez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 26, 2006
Cooperative activity of cytotoxic chemotherapy with antiangiogenic thrombospondin-I peptides, ABT-526 in pet dogs with relapsed lymphomaAnthony Rusk, Elizabeth Cozzi, Marty Stebbins, et al.
Viruses|March 28, 2024
The NDV-MLS as an Immunotherapeutic Strategy for Breast Cancer: Proof of Concept in Female Companion Dogs with Spontaneous Mammary CancerDiana Sánchez, Gabriela Cesarman-Maus, Laura Romero, et al.
Veterinary and Comparative Oncology|April 30, 2020
Rabacfosadine for naïve canine intermediate to large cell lymphoma: Efficacy and adverse event profile across three prospective clinical trialsCorey F Saba, Craig Clifford, Kristine Burgess, et al.
Plos One|June 20, 2015
Defining the Pharmacodynamic Profile and Therapeutic Index of NHS-IL12 Immunocytokine in Dogs with Malignant MelanomaMelissa Paoloni, Christina Mazcko, Kimberly Selting, et al.
Plos One|March 31, 2009
Launching a novel preclinical infrastructure: comparative oncology trials consortium directed therapeutic targeting of TNFalpha to cancer vasculatureMelissa C Paoloni, Anita Tandle, Christina Mazcko, et al.
Plos One|March 19, 2014
Prospective molecular profiling of canine cancers provides a clinically relevant comparative model for evaluating personalized medicine (PMed) trialsMelissa Paoloni, Craig Webb, Christina Mazcko, et al.
Pageof 2